Beta Glucan Market Overview:

According to IMARC Group's latest research publication, "Beta Glucan Market Report by Type (Soluble, Insoluble), Source (Cereal, Mushroom, Yeasts, Seaweed), Industry Vertical (Animal Feed, Personal Care and Cosmetics, Pharmaceuticals, and Others), and Region 2026-2034", The global beta glucan market size was valued at USD 582.7 Million in 2025 and is projected to reach USD 991.4 Million by 2034, exhibiting a CAGR of 5.90% during 2026-2034.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How Innovation is Reshaping the Future of the Beta Glucan Market

• The European Food Safety Authority (EFSA) has confirmed that oat beta-glucan minimizes blood cholesterol levels, while the U.S. Food and Drug Administration (FDA) recognizes oat beta-glucan as part of a diet that may reduce the risk of developing heart diseases, directly validating demand for beta-glucan enriched functional foods.

• Government-backed health awareness initiatives across Europe and North America are actively encouraging consumers to adopt natural bioactive compounds, creating a sustained pipeline of demand for beta-glucan ingredients in both food and pharmaceutical applications.

• Companies like BENEO have introduced clean-label barley-derived beta-glucan ingredients, such as Orafti Beta-Fit, a whole-grain barley flour containing 20% beta-glucans, catering to growing consumer demand for sustainable and plant-based nutritional solutions.

• Kemin Industries received a positive opinion from the EFSA for BetaVia Pure, an algae-based postbiotic ingredient, marking a significant regulatory milestone that opens the door to broader commercial applications of algae-sourced beta-glucan across the European market.

• Skincare brands are increasingly incorporating yeast-derived beta-glucan into formulations, with clinical data showing that beta-glucan can increase skin softness by up to 21% and hydration by up to 23%, outperforming hyaluronic acid in certain applications by as much as 20%, according to industry specialists.

Download a sample PDF of this report: https://www.imarcgroup.com/beta-glucan-market/requestsample

Key Trends in the Beta Glucan Market

• Surging Demand for Natural Immunity Boosters: The rising prevalence of lifestyle diseases including diabetes, cardiovascular ailments, and obesity is pushing consumers toward natural bioactive solutions. Beta-glucan's immune-modulating properties have earned recognition from institutions like the National Cancer Institute (NCI), which identifies yeast-derived beta-glucan as having potential anti-inflammatory, antioxidant, and immunomodulatory benefits, fueling widespread consumer adoption.

• Beta-Glucan Breaking into Premium Skincare: Beta-glucans are gaining extensive traction in personal care owing to their skin-soothing and anti-inflammatory properties. High-performance luxury brands like RéVive now feature beta-glucan in serums targeting fine lines and wrinkles, while biotechnology companies such as Sawubona Mycelium have launched dedicated mushroom mycelium-derived beta-glucan skincare lines, underlining the ingredient's premium positioning.

• Non-GMO and Clean Label Formulations on the Rise: The escalating preference for organic, non-GMO, and sustainably sourced products is reshaping the competitive landscape. NutriScience Innovations' BGF-Immune, a clinically studied 1,3-beta-glucan ingredient, became a non-GMO project verified product, while Sunny Boy Foods produces Cerabeta using 100% non-GMO barley grains with zero chemicals or enzymes, demonstrating how clean sourcing is becoming a market differentiator.

• Algae Emerging as a Next-Generation Beta-Glucan Source: Consumers are increasingly recognizing algae as a superfood source, prompting companies like Kemin Industries to launch water-dispersible algae-sourced beta-glucan products such as BetaVia Complete WD and BetaVia Pure WD, formulated for application in drink mixes and sachets with clinically validated immune support.

• Innovative Delivery Formats Expanding Market Reach: The growing popularity of convenient nutritional supplements is prompting companies to explore new delivery formats. Kerry introduced a non-GMO and gluten-free range of fruit-flavored beta-glucan gummies in India, while Lantmännen Functional Foods launched PromOat Instant, the first oat beta-glucan that is 100% soluble in water, broadening accessibility for consumers across functional beverage and supplement categories.

Growth Factors in the Beta Glucan Market

• Soluble Beta-Glucan Leading Functional Applications: Soluble beta-glucan commands the largest type segment, with its ease of incorporation into functional foods, beverages, and dietary supplements making it the preferred form for manufacturers. Products like Beneo's Orafti Beta-Fit, which is easily soluble in water, exemplify how solubility is a key commercial driver.

• Yeast-Derived Beta-Glucan Dominating Source Segment: Yeast accounts for the largest share among all source categories, driven by its high purity, bioactivity, and well-established skin-soothing benefits. Rising investments in clinical trials further support the segment, with yeast-derived formulations finding application in both pharmaceutical adjuncts and premium personal care products.

• Animal Feed Sector Leveraging Immunomodulatory Benefits: In the animal feed vertical, beta-glucan is widely recognized for its ability to support gut health and modulate immunity, making it an increasingly important ingredient for livestock producers seeking natural performance enhancers as antibiotic alternatives come under regulatory scrutiny globally.

• BFSI-Level Regulatory Validation Strengthening Pharmaceutical Demand: In the pharmaceutical vertical, beta-glucan is used as an adjunct in treatments across multiple conditions. Companies like Immudyne Nutritional have developed beta-glucan ingredients such as PureMune, produced in FDA-registered facilities, signaling the ingredient's growing pharmaceutical-grade credibility.

• Europe's Regulatory Framework Accelerating Regional Growth: Europe dominates the global market, underpinned by the EFSA's recognized health claims for oat beta-glucan related to cholesterol management. Companies like Teijin have signed agency contracts with Italian distributors such as Garzanti Specialties to sell BARLEYmax, a beta-glucan-rich dietary fiber product, actively expanding the ingredient's footprint across the European food supplements market.

Leading Companies Operating in the Global Beta Glucan Industry:

• Biorigin
• COSCIENS Biopharma Inc
• Garuda International, Inc
• Givaudan
• Kemin Industries, Inc
• Kerry Group plc
• Lallemand Inc
• Lantmännen Biorefineries
• Lesaffre
• Super Beta Glucan
• VW-Ingredients

Beta Glucan Market Report Segmentation:

Breakup By Type:

• Soluble
• Insoluble

Soluble accounts for the majority of shares on account of its broad compatibility with functional food, beverage, and supplement applications and superior consumer acceptance.

Breakup By Source:

• Cereal
• Mushroom
• Yeasts
• Seaweed

Yeasts dominate the source segment due to the high purity and bioactivity of yeast-derived beta-glucan, along with its dual utility across skincare and immune health applications.

Breakup By Industry Vertical:

• Animal Feed
• Personal Care and Cosmetics
• Pharmaceuticals
• Others

Animal feed, personal care and cosmetics, and pharmaceuticals collectively represent the primary verticals, with each segment benefiting from beta-glucan's proven immunomodulatory, skin-enhancing, and therapeutic properties.

Breakup By Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Europe enjoys the leading position owing to a robust regulatory framework, widespread consumer adoption of beta-glucan for cholesterol management and immunity support, and the active product development activity of regional businesses.

Recent News and Developments in the Beta Glucan Market

• April 2024: Kemin Industries received the novel food authorization from the European Commission for BetaVia Pure, which contains a 95% beta 1,3 glucan concentration, marking a landmark regulatory approval that strengthens the ingredient's commercial viability across European food and supplement markets.

• March 2024: Solabia-BioActor received an approval letter from the U.S. Food and Drug Administration (FDA) regarding their Generally Recognized as Safe (GRAS) application for its women's health ingredient Bonolive, reinforcing the regulatory momentum around bioactive ingredient platforms in the North American market.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302